These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3457785)

  • 1. Antibacterial activity of enoxacin: comparison with aminoglycosides, beta-lactams and other antimicrobial agents.
    Vanhoof R; Hubrechts JM; Roebben E; Claeys M; Nyssen HJ
    J Antimicrob Chemother; 1986 Mar; 17(3):297-302. PubMed ID: 3457785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
    Chin NX; Neu HC
    Antimicrob Agents Chemother; 1983 Nov; 24(5):754-63. PubMed ID: 6229216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activities of enoxacin (CI-919, AT-2266) and eleven antipseudomonal agents against aminoglycoside-susceptible and -resistant Pseudomonas aeruginosa strains.
    Bassey CM; Baltch AL; Smith RP; Conley PE
    Antimicrob Agents Chemother; 1984 Sep; 26(3):417-8. PubMed ID: 6439116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates.
    Duncan IB; Skulnick M; Marshall PW
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():1-6. PubMed ID: 6438046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies].
    Prado V; Reyes L
    Rev Med Chil; 1985 Feb; 113(2):94-102. PubMed ID: 3866270
    [No Abstract]   [Full Text] [Related]  

  • 6. In-vitro activity of pefloxacin compared to enoxacin, norfloxacin, gentamicin and new beta-lactams.
    Clarke AM; Zemcov SJ; Campbell ME
    J Antimicrob Chemother; 1985 Jan; 15(1):39-44. PubMed ID: 3156112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of enoxacin, ticarcillin plus clavulanic acid, aztreonam, piperacillin, and imipenem and comparison with commonly used antimicrobial agents.
    Henry D; Skidmore AG; Ngui-Yen J; Smith A; Smith JA
    Antimicrob Agents Chemother; 1985 Aug; 28(2):259-64. PubMed ID: 3869433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro susceptibility of Pseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides.
    Van der Auwera P; Schuyteneer F
    J Antimicrob Chemother; 1983 Jun; 11(6):511-5. PubMed ID: 6411673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents.
    Wise R; Andrews JM; Danks G
    J Antimicrob Chemother; 1984 Mar; 13(3):237-44. PubMed ID: 6586712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of enoxacin compared with norfloxacin and amikacin.
    van der Auwera P; de Moor G; Lacroix G; Mambour A; Rossion N; Schuyteneer F
    Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
    Baltch AL; Bassey C; Fanciullo G; Smith RP
    J Antimicrob Chemother; 1987 Jan; 19(1):45-8. PubMed ID: 3104277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A laboratory assessment of ciprofloxacin and comparable antimicrobial agents.
    Shrire L; Saunders J; Traynor R; Koornhof HJ
    Eur J Clin Microbiol; 1984 Aug; 3(4):328-32. PubMed ID: 6237900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antibacterial activity of enoxacin, a new pyridonecarboxylic acid.
    Fabio U; Bondi M; Galletti F; Manicardi G; Messi P; Neglia R; Casolari C
    Boll Ist Sieroter Milan; 1987; 66(2):110-5. PubMed ID: 3478050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative antibacterial activities of new beta-lactam antibiotics against Pseudomonas aeruginosa.
    Fernandes CJ; Stevens DA; Ackerman VP
    Chemotherapy; 1985; 31(4):292-6. PubMed ID: 3928282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity.
    Reeves DS; Bywater MJ; Holt HA
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():7-17. PubMed ID: 6594324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro sensitivity at 18 antibiotics of 192 strains of Pseudomonas aeruginosa isolated at Garches Hospital].
    Ronco E; Vacheron F; Orabona A
    Pathol Biol (Paris); 1987 May; 35(5):558-62. PubMed ID: 3112708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
    Chartrand SA; Scribner RK; Weber AH; Welch DF; Marks MI
    Antimicrob Agents Chemother; 1983 May; 23(5):658-63. PubMed ID: 6223577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.